Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative; 14 september Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative; Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative;Crohn Disease, Date of authorisation: 22/05/2014, Revision: 25, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief.